NCT00138697View on ClinicalTrials.gov

Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2001

Study Completion Date

December 31, 2004

Conditions
Hypogammaglobulinemia
Interventions
DRUG

IVIG-L

Trial Locations (6)

1815 JD

Medical Centre Alkmaar, Alkmaar

1100 DD

Academic Medical Centre, Amsterdam

9700 RB

Academic Hospital Groningen, Groningen

2333 ZA

LUMC, Leiden

6525 GA

UMC St. Radboud, Nijmegen

2545 CH

Leyenburg Hospital, The Hague

Sponsors
All Listed Sponsors
lead

Prothya Biosolutions

INDUSTRY